Content about Prestige Brands

July 2, 2012

Prestige Brands earlier this year completed its acquisition of 17 GlaxoSmithKline brands. DSN sat with Prestige SVP sales and marketing Tim Connors to discuss what’s next.

AUDIO Q&A: DSN sat with Tim Connors, Prestige Brands SVP sales and marketing, to discuss what’s next after the company earlier this year completed its acquisition of 17 GlaxoSmithKline brands.

April 15, 2014

Prestige Brands on Tuesday announced the signing of a purchase agreement for the acquisition of Hydralyte in Australia and New Zealand from the Hydration Pharmaceuticals Trust of Victoria, Australia.

TARRYTOWN, N.Y. — Prestige Brands on Tuesday announced the signing of a purchase agreement for the acquisition of Hydralyte in Australia and New Zealand from the Hydration Pharmaceuticals Trust of Victoria, Australia. The acquisition is expected to close, subject to customary closing conditions, during the company's first quarter of fiscal 2015, which began on April 1, 2014.

February 7, 2014

Cough-cold suppliers are presently operating in a challenging environment, noted Matthew Mannelly, Prestige Brands CEO, president and director, during a conference call Thursday.

TARRYTOWN, N.Y. — Cough-cold suppliers are presently operating in a challenging environment, noted Matthew Mannelly, Prestige Brands CEO, president and director, during a conference call Thursday. The return of Tylenol to the cough-cold aisle and the accompanying media splash from McNeil Consumer isn't the only competitive factor impacting the cough-cold category, Mannelly said. The season is down more than 15% versus last year. And that lack of consumption, coupled with an overall soft retail environment, is forcing retailers to significantly cut back on inventories. 

September 24, 2013

Fortune has named Prestige Brands as one of its 100 fastest-growing companies, Prestige announced Tuesday. Listed as No. 60, Prestige represents the only manufacturer of brand name over-the-counter healthcare products on the list.

TARRYTOWN, N.Y. — Fortune has named Prestige Brands as one of its 100 fastest-growing companies, Prestige announced Tuesday. Listed as No. 60, Prestige represents the only manufacturer of brand name over-the-counter healthcare products on the list. 

July 9, 2013

Prestige Brands Holdings announced its acquisition of Care Pharmaceuticals of Bondi Junction, New South Wales, Australia, a privately held marketer and distributor of over-the-counter healthcare brands for children and adults.

TARRYTOWN, N.Y. — Prestige Brands Holdings on Tuesday announced its acquisition of Care Pharmaceuticals of Bondi Junction, New South Wales, Australia, a privately held marketer and distributor of over-the-counter healthcare brands for children and adults. 

June 1, 2013

GMDC and FMI are co-hosting the Health & Wellness @Retail 2013 conference in San Antonio from May 31 to June 3. Below are some of our editors' picks of the hot products at the show.

GMDC and FMI are co-hosting the Health & Wellness @Retail 2013 conference in San Antonio from May 31 to June 3. Below are some of our editors' picks of the hot products at the show.

May 16, 2013

The booming 2012-2013 cough-cold season may not have come with a fresh set of challenges for the 2013-2014 season.

TARRYTOWN, N.Y. — The booming 2012-2013 cough-cold season may not have come with a fresh set of challenges for the 2013-2014 season. Retailers who had to beef up their cold and flu remedy supplies in the latter half of the season may not need to order as heavily over the summer as they may have in the past. A late start to the allergy season also is reducing the need for cough-cold stock. 

February 7, 2013

Reporting on the third quarter ended Dec. 31, Prestige Brands' CEO Matthew Mannelly told analysts he is "cautiously optimistic" regarding cough-cold reorders given the high consumption levels at retail in late December through January.

TARRYTOWN, N.Y. — Reporting on the third quarter ended Dec. 31, Prestige Brands' CEO Matthew Mannelly told analysts Thursday morning he is "cautiously optimistic" regarding cough-cold reorders given the high consumption levels at retail in late December through January. 

September 24, 2012

Prestige Brands on Monday announced the launch of Goody's in a caplet format.

IRVINGTON, N.Y. — Prestige Brands on Monday announced the launch of Goody's in a caplet format. The pain reliever had long been sold as a powder. 

July 30, 2012

Prestige Brands on Monday announced the home stretch for its consumer-created jingle-development contest for its Luden's cough drop brand.

IRVINGTON, N.Y. — Prestige Brands on Monday announced the home stretch for its consumer-created jingle-development contest for its Luden's cough drop brand. Playing off of the theme “Surprisingly Soothing, Simply Delicious!” online voting for the top 10 finalists to determine the grand prize winner in the La La Luden’s contest runs through Aug. 17.

Ten finalists have been selected and their videos are now up on Luden’s website for viewing and voting.

July 25, 2012

Cutex's latest nail polish remover has arrived on store shelves at select Walmart stores nationwide.

ST. LOUIS — Cutex's latest nail polish remover has arrived on store shelves at select Walmart stores nationwide.

First launched in March, the Advanced Revival nail polish remover combines an acetone-based formula with natural botanical nourishing oils for stronger, healthier nails, the company said.

July 16, 2012

Prestige Brands earlier this year completed its acquisition of 17 GlaxoSmithKline brands. Drug Store News sat with Prestige SVP sales and marketing Tim Connors to discuss what’s next.


Prestige Brands earlier this year completed its acquisition of 17 GlaxoSmithKline brands. Drug Store News sat with Prestige SVP sales and marketing Tim Connors to discuss what’s next.


DSN: What is the next step? 


Tim Connors: Our strategic value creation plan consists of three components: 


June 21, 2012

This may be the year of the legacy brands as two companies that recently acquired separate brand portfolios from GlaxoSmithKline focus on reinvigorating consumer attention to their respective product lines.


This may be the year of the legacy brands as two companies that recently acquired separate brand portfolios from GlaxoSmithKline focus on reinvigorating consumer attention to their respective product lines.


Prestige Brands will be adding 17 former GSK brands to its stable of legacy brands that already includes Luden’s and Dramamine. The company recently identified the five key GSK-acquired brands that Prestige will be focusing on in terms of both marketing support and new product development — BC, Goody’s, Debrox, Gaviscon and Beano.


June 21, 2012

Biolife in May launched WoundSeal, a hemostat product specifically targeting Americans on a regimen of blood thinners. While hemostat products have been introduced into the first aid set before, this is the first one targeting patients on a specific therapy.


SUPPLIER NEWS — Biolife in May launched WoundSeal, a hemostat product specifically targeting Americans on a regimen of blood thinners. While hemostat products have been introduced into the first aid set before, this is the first one targeting patients on a specific therapy.


May 17, 2012

Prestige Brands on Thursday morning announced the launch of Dramamine for Kids.

IRVINGTON, N.Y. — Prestige Brands on Thursday morning announced the launch of Dramamine for Kids, noting that 34% of households (with children between the ages of 2 years and 12 years) have a child with motion sickness. According to the company, it is estimated that one-third of moms currently are using a Dramamine adult formula but would prefer a pediatric product.

May 17, 2012

Prestige Brands closed out its fiscal 2012 ended March 31 on a high note with $441.1 million in revenues for the year, up 31.1%. And fiscal 2013 is looking promising as the company will have full-year contributions from its 17 acquired over-the-counter brands from GlaxoSmithKline.

IRVINGTON, N.Y. — Prestige Brands closed out its fiscal 2012 ended March 31 on a high note with $441.1 million in revenues for the year, up 31.1%. And fiscal 2013 is looking promising as the company will have full-year contributions from its 17 acquired over-the-counter brands from GlaxoSmithKline.

May 3, 2012

Prestige Brands on Thursday acknowledged that Genomma Lab has withdrawn its unsolicited acquisition proposal.

IRVINGTON, N.Y. — Prestige Brands on Thursday acknowledged that Genomma Lab has withdrawn its unsolicited acquisition proposal.

April 27, 2012

Prestige Brands on Thursday reiterated its rebuke of a buyout offer from Mexican healthcare supplier Genomma Lab Internacional following Genomma's release of a proposal presentation.

IRVINGTON, N.Y. — Prestige Brands on Thursday reiterated its rebuke of a buyout offer from Mexican healthcare supplier Genomma Lab Internacional following Genomma's release of a proposal presentation.

April 3, 2012

Prestige Brands Holdings on Monday announced that it has completed the purchase of the two remaining brands of the 17 brands it agreed to acquire from GlaxoSmithKline; the purchase of Debrox ear wax remover and Gly-Oxide oral rinse completes the transaction.

IRVINGTON, N.Y. — Prestige Brands Holdings on Monday announced that it has completed the purchase of the two remaining brands of the 17 brands it agreed to acquire from GlaxoSmithKline; the purchase of Debrox ear wax remover and Gly-Oxide oral rinse completes the transaction.

For all 17 brands, Prestige paid a total of $660 million in cash plus a customary post-closing inventory adjustment under the original terms of the agreements.

March 16, 2012

Genomma Lab is planning to present a list of candidates to serve on the board of directors of Prestige Brands.

IRVINGTON, N.Y. — Genomma Lab is planning to present a list of candidates to serve on the board of directors of Prestige Brands.

The announcement followed Genomma Lab's unsolicited proposal to acquire Prestige Brands for $16.60 per share in cash. Although the deal was rejected, Genomma Lab intends to present the list at Prestige Brands' upcoming annual meeting in June.

March 13, 2012

Prestige Brands has rejected an unsolicited proposal from Genomma Lab, which seeks to acquire the over-the-counter and household cleaning products maker for $16.60 per share in cash, calling the deal inadequate, opportunistic and highly conditional.

IRVINGTON, N.Y. — Prestige Brands has rejected an unsolicited proposal from Genomma Lab, which seeks to acquire the over-the-counter and household cleaning products maker for $16.60 per share in cash, calling the deal inadequate, opportunistic and highly conditional.

March 7, 2012

Cutex has introduced Advanced Revival, which, according to the manufacturer, marks the first innovation in nail polish remover formula in more than 15 years.

ST. LOUIS — Cutex has introduced Advanced Revival, which, according to the manufacturer, marks the first innovation in nail polish remover formula in more than 15 years.

Advanced Revival combines an acetone-based formula with natural botanical nourishing oils for stronger, healthier nails, the company said.

February 22, 2012

Prestige Brands will take an acquisition offer from Genomma Lab Internacional under advisement, the company announced Tuesday evening.

IRVINGTON, N.Y. — Prestige Brands will take an acquisition offer from Genomma Lab Internacional under advisement, the company announced Tuesday evening.

Prestige Brands confirmed the company's receipt of a non-binding letter from Genomma Lab Internacional, proposing to acquire all outstanding common shares of Prestige Brands at a price of $16.60 per share in cash.

February 2, 2012

Prestige Brands on Tuesday announced that it has completed its previously announced purchase of 15-of-the-17 brands it agreed to acquire from GlaxoSmithKline.

IRVINGTON, N.Y. — Prestige Brands on Tuesday announced that it has completed its previously announced purchase of 15-of-the-17 brands it agreed to acquire from GlaxoSmithKline.

Prestige did not identify the two brand acquisitions not yet completed.

The former GSK brands represent approximately $200 million in annual revenues, which is projected to push Prestige annual revenues above $600 million, Prestige stated in an investor presentation in December.

December 20, 2011

Prestige on Tuesday acquired 17 over-the-counter brands from GlaxoSmithKline for a total of $660 million in cash.

IRVINGTON, N.Y. — Prestige on Tuesday acquired 17 over-the-counter brands from GlaxoSmithKline for a total of $660 million in cash. Among the brands Prestige acquired are the pain relievers BC, Goody's and Ecotrin brands; digestive brands Beano, Gaviscon, Phazyme, Tagamet and Fiber Choice; and the Sominex sleep aid brand.